Rational design of protamine nanocapsules as antigen delivery carriers
Current challenges in global immunization indicate the demand for new delivery strategies, which could be ap_x0002_plied to the development of new vaccines against emerging diseases, as well as to improve safety and efficacy of currently existing vaccine formulations. Here, we report a novel antigen nanocarrier consisting of an oily core and a protamine shell, further stabilized with pegylated surfactants. These nanocarriers, named protamine nanocapsules, were rationally designed to promote the intracellular delivery of antigens to immunocompetent cells and to trigger an efficient and long-lasting immune response. Protamine nanocapsules have nanometric size, positive zeta potential and high association capacity for H1N1 influenza hemagglutinin, a protein that was used here as a model antigen. The new formulation shows an attractive stability profile both, as an aqueous sus_x0002_pension or a freeze-dried powder formulation. In vitro studies showed that protamine nanocapsules were effi_x0002_ciently internalized by macrophages without eliciting significant toxicity. In vivo studies indicate that antigen_x0002_loaded nanocapsules trigger immune responses comparable to those achieved with alum, even when using sig_x0002_nificantly lower antigen doses, thus indicating their adjuvant properties. These promising in vivo data, alongside with their versatility for the loading of different antigens and oily immunomodulators and their excellent stability profile, make these nanocapsules a promising platform for the delivery of antigens. Chemical compounds: Protamine sulphate (PubChem SID: 7849283), Sodium Cholate (PubChem CID: 23668194), Miglyol (PubChem CID: 53471835), α tocopherol (PubChem CID: 14985), Tween® 20(PubChem CID: 443314), Tween® 80(PubChem CID: 5281955), TPGS (PubChem CID: 71406).
Main Authors: | , , , , , , , |
---|---|
Format: | artículo biblioteca |
Language: | English |
Published: |
Elsevier
2017
|
Subjects: | Protamine, Nanocapsules, Antigen delivery, Vaccine, Influenza vaccine, Adjuvant, |
Online Access: | http://hdl.handle.net/20.500.12792/1884 http://hdl.handle.net/10261/291321 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|